Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended September 30, 2009, for Zeta Acquisition Corp. II (not Whitehawk Therapeutics, Inc., as indicated in the metadata). The registrant is a Delaware corporation classified as a "shell company" and a "blank check" company in the development stage. Its sole business objective is to investigate and acquire a target company to achieve long-term growth potential. The company has no specific business plan or operations other than seeking a business combination.
Key Financial Metrics
| Metric | Value (Sep 30, 2009) | Value (Dec 31, 2008) |
|---|---|---|
| Revenue | $0 | $0 |
| Net Loss (9 Months) | $(12,529) | $(24,515) |
| Cash and Cash Equivalents | $13,031 | $7,508 |
| Total Assets | $16,031 | $7,508 |
| Total Liabilities | $27,160 | $6,108 |
| Stockholders' Equity (Deficit) | $(11,129) | $1,400 |
| Notes Payable (Stockholders) | $25,000 | $0 |
| Net Cash Used in Operating Activities (9 Months) | $(19,477) | $(29,989) |
| Net Cash Provided by Financing Activities (9 Months) | $25,000 | $0 |
Note: The company has generated no revenue since inception (November 16, 2007). Cumulative net loss since inception is $61,129.
Material Changes vs. Prior Period
- Liabilities: Total liabilities increased from $6,108 to $27,160, primarily due to the issuance of $25,000 in unsecured promissory notes to stockholders during the period.
- Equity: Stockholders' equity shifted from a positive balance of $1,400 to a deficit of $(11,129) due to the accumulation of operating losses.
- Cash Position: Cash and cash equivalents increased by $5,523 to $13,031, driven by financing proceeds from stockholders offsetting operating cash burn.
- Operating Expenses: Net loss for the nine months ended September 30, 2009 ($12,529) was lower than the same period in 2008 ($24,515), reflecting reduced professional fees for filings and formation costs.
Outlook, Risks, and Management Commentary
- Liquidity Risk: The company explicitly states it cannot assure it can satisfy cash requirements for the next twelve months. It is dependent on capital investment or loans from related parties (stockholders) to fund operations and search for a target.
- Going Concern: Financial statements are presented on a going concern basis, which assumes the company will continue operations. However, the lack of revenue and reliance on external funding raise substantial doubt about this ability without a successful business combination.
- Business Plan: The company intends to file periodic reports and investigate acquisition targets. It may acquire financially unstable or early-stage companies, which introduces significant risk.
- Related Party Transactions: The company utilizes office space and equipment from an officer/director at no cost. Additionally, the $25,000 in notes payable are owed to stockholders, bearing 6% interest and due on demand.
- Unusual Items: No off-balance sheet arrangements exist. The company is a "smaller reporting company" and is exempt from certain contractual obligation and risk factor disclosures.
Investor Verification Checklist
- Verify the company's ability to secure additional funding from stockholders or third parties to cover operating costs for the next 12 months.
- Confirm the status of the $25,000 in notes payable to stockholders and any potential conversion terms or repayment demands.
- Assess the progress of the search for a target business combination, as the company has no operations or revenue without an acquisition.
- Review the cumulative deficit of $(61,129) and the valuation allowance on deferred tax assets, indicating no current tax benefit realization.
- Check for any subsequent events or changes in the "shell company" status that might affect the ability to merge with a private operating company.